Method of treating amytrophic lateral sclerosis using melatonin

Details Method of treating amytrophic lateral sclerosis using melatonin Method of treating amytrophic lateral sclerosis using melatonin

2008-04-22

2008-04-22

Kim, Jennifer (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S419000, C514S367000

Reexamination Certificate

active

07361681

ABSTRACT:
The present invention relates to the treatment of amyotrophic lateral sclerosis (ALS) and/or the improvement of motor function in individuals in need of such improvement using a melatonin compound or a pharmaceutical salt of the melatonin compound.

REFERENCES:
patent: 3642994 (1972-02-01), Fernando
patent: 5591768 (1997-01-01), Lewy et al.
patent: 5700828 (1997-12-01), Federowicz et al.
patent: 5780489 (1998-07-01), Brooks
patent: 6004991 (1999-12-01), Fourtillan et al.
patent: 6274615 (2001-08-01), Pappolla et al.
patent: 6353015 (2002-03-01), Oxenkrug et al.
patent: 6436984 (2002-08-01), Ducrocq et al.
patent: 6458384 (2002-10-01), Jaenicke et al.
patent: 6469049 (2002-10-01), Meyerhoff et al.
Bowling et al. Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sciences, 1995, vol. 56, No. 14, pp. 1151-1171.
J. Pineal Research, 2002; 33:186-187, Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALIS patients.
Iacovitti, et al. Brain Research, 768 (1997) 317-326, Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress.
Cazevieille, et al., Brain Research, 768 (1997) 12-24, Melatonin protects primary cultures of rat cortical neurons from NMDA excitotoxicity and hypoxial/reoxygenation.
General Anti Oxidant Information, Feb. 1998, www.home.goulbum.net.au/shack/antioxidants.htm.

Affiliated with

Also associated with

Rating

Method of treating amytrophic lateral sclerosis using melatonin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating amytrophic lateral sclerosis using melatonin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating amytrophic lateral sclerosis using melatonin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2783759